Invivyd, Inc.

IVVD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001832038

Price chart

Open-market purchases and sales by IVVD insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Aug 18, 20268:10 PM ETAug 17 – Aug 18, 2026Lee Timothy EdwardChief Commercial OfficerSSaleCommon Stock−40.78K$0.7766−$31.67K178.94K−18.6%SEC10b5-1
Aug 18, 20268:10 PM ETAug 17 – Aug 18, 2026Green JulieChief Human Resources OfficerSSaleCommon Stock−40.78K$0.7766−$31.67K168.94K−19.4%SEC10b5-1
Aug 18, 20268:10 PM ETAug 17 – Aug 18, 2026Duke William E.Chief Financial OfficerSSaleCommon Stock−40.78K$0.7766−$31.67K168.94K−19.4%SEC10b5-1
Aug 18, 20268:10 PM ETAug 17 – Aug 18, 2026Andersen JillChief Legal Officer, SecretarySSaleCommon Stock−67.96K$0.7766−$52.78K283.77K−19.3%SEC10b5-1
Aug 18, 20268:10 PM ETAug 17 – Aug 18, 2026Allen Robert D. IIIChief Scientific OfficerSSaleCommon Stock−37.72K$0.7766−$29.3K178.77K−17.4%SEC10b5-1

The largest institutional positions in IVVD at the end of Q2 2026.

Institutions holding IVVD in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Jupiter Topco LLC34,173,104$30.05M0.01%+34,173,104New
BVF INC/IL28,165,000$24.57M0.63%+8,640,000+44.3%Added
MAVERICK CAPITAL LTDSuperinvestorMaverick Capital18,970,913$16.55M0.15%00.0%Unchanged
PERCEPTIVE ADVISORS LLC18,490,636$16.13M0.25%−2,368,667−11.4%Reduced
BlackRock, Inc.16,134,885$14.08M0.00%+11,853,095+276.8%Added